Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study ( vol 23 , 57 , 2024)Phyo T. Htoo,Helen Tesfaye,Sebastian Schneeweiss,Deborah J. Wexler,Brendan M. Everett,Robert J. Glynn,Niklas Schmedt,Lisette Koeneman,Anouk Deruaz-Luyet,Julie M. Paik,Elisabetta PatornoCARDIOVASCULAR DIABETOLOGY（2024）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
